Skip to main content

Table 2 The Venn diagram proteins whose levels differed during CRC progression in all locations

From: Differences and overlap in plasma protein expression during colorectal cancer progression

Proteins whose plasma levels differed between samples from patients with stage II and III cancer in all locations  
Accession Peptide count Unique peptides Confidence score Protein name Gene name Notes
Q15166 6 2 62,1 Serum paraoxonase/lactonase 3 PON3 *
P02766 22 19 214,4 Transthyretin TTR  
P02775 9 7 66,0 Platelet basic protein PPBP *
O95568 8 3 32,4 Histidine protein methyltransferase 1 homolog METTL18  
Q12805 9 8 51,7 EGF-containing fibulin-like extracellular matrix protein 1 EFEMP1  
Q8TE85 6 3 28,7 Grainyhead-like protein 3 homolog GRHL3  
P05455 5 3 28,9 Lupus La protein SSB *
A6NMZ7;P51570;Q13158;Q6NT55 5 2 24,3 Collagen alpha-6(VI) chain COL6A6  
P09871 54 47 387,7 Complement C1s subcomponent C1S  
O75882 16 12 98,9 Attractin ATRN  
P23508 5 3 27,9 Colorectal mutant cancer protein MCC *
P02790;P51687;Q00973;Q04917;Q5T013;Q9NXR7; Q9NZ08;Q9Y2H2;Q9Y2K5;V9GYY9 182 150 1011,0 Hemopexin HPX  
P07357 35 34 217,4 Complement component C8 alpha chain C8A  
  1. These 13 proteins are those whose changes in levels were common to CRC progression regardless of tumor location. Accession, peptide count, unique peptides, confidence score, protein name, and gene name are given in the table. The proteins with higher levels in samples from patients with left-sided stage III than stage II CRC are marked with a *. All other proteins had higher levels in patients with stage II cancer